Compile Data Set for Download or QSAR
Report error Found 165 of ph data with Target = 'Complement factor B'
TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 289502BDBM289502(US10093663, Example 27-4a)
Affinity DataIC50: 9nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 159970BDBM159970(US9682968, Example-20a | US10093663, Example 20a)
Affinity DataIC50: 9nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 160475BDBM160475(US9682968, Example-26a | US10093663, Example 26b |...)
Affinity DataIC50: 10nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 159938BDBM159938(US9682968, Example-17-29 | US10093663, Example 17-...)
Affinity DataIC50: 11nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 289488BDBM289488(US10093663, Example 22-2b)
Affinity DataIC50: 13nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 159545BDBM159545(US9682968, Example-17-30 | US9682968, Example-17-1...)
Affinity DataIC50: 13nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 289500BDBM289500(US10093663, Example 27-3a)
Affinity DataIC50: 14nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 159486BDBM159486(US9682968, Example-17-11 | US10093663, Example 17-...)
Affinity DataIC50: 15nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 289498BDBM289498(US10093663, Example 27-2a)
Affinity DataIC50: 15nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 160036BDBM160036(US9682968, Example-21a | US10093663, Example 21a)
Affinity DataIC50: 19nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 289485BDBM289485(US10093663, Example 22-1a)
Affinity DataIC50: 19nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 159312BDBM159312(US9682968, Example-17-1 | US10093663, Example 17-1)
Affinity DataIC50: 19nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 160499BDBM160499(US9682968, Example-36 | US10093663, Example 36)
Affinity DataIC50: 20nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 160500BDBM160500(US9682968, Example-37 | US10093663, Example 37)
Affinity DataIC50: 22nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 289497BDBM289497(US10093663, Example 27-1b)
Affinity DataIC50: 22nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 181732BDBM181732(US9676728, 5 b (-)-2-(2,2,2-Trifluoro-1-(2-methoxy...)
Affinity DataIC50: 23nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/16/2018
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 159545BDBM159545(US9682968, Example-17-30 | US9682968, Example-17-1...)
Affinity DataIC50: 23nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 159566BDBM159566(US9682968, Example-17-18 | US10093663, Example 17-...)
Affinity DataIC50: 27nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251874BDBM251874(US9475806, 8-B b) (-))
Affinity DataIC50: 30nMpH: 7.4 T: 2°CAssay Description:Recombinant human factor B (expressed in drosophila cells and purified using standard methods) labeled with biotin (10 nM), europium-labeled streptav...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 289450BDBM289450(US10093663, Example 17-5 | US10093663, Example 17-...)
Affinity DataIC50: 30nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 159311BDBM159311(US9682968, Example-16 | US10093663, Example 16)
Affinity DataIC50: 30nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251876BDBM251876(US9475806, 9-D b) (-))
Affinity DataIC50: 30nMpH: 7.4 T: 2°CAssay Description:Recombinant human factor B (expressed in drosophila cells and purified using standard methods) labeled with biotin (10 nM), europium-labeled streptav...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 159873BDBM159873(US9682968, Example-17-24 | US10093663, Example 17-...)
Affinity DataIC50: 35nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 159289BDBM159289(US9682968, Example-5-12 | US10093663, Example 5-12)
Affinity DataIC50: 37nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 289451BDBM289451(US10093663, Example 17-3)
Affinity DataIC50: 38nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251882BDBM251882(US9475806, 12-D)
Affinity DataIC50: 40nMpH: 7.4 T: 2°CAssay Description:Recombinant human factor B (expressed in drosophila cells and purified using standard methods) labeled with biotin (10 nM), europium-labeled streptav...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251878BDBM251878(US9475806, 10-B b) (-))
Affinity DataIC50: 40nMpH: 7.4 T: 2°CAssay Description:Recombinant human factor B (expressed in drosophila cells and purified using standard methods) labeled with biotin (10 nM), europium-labeled streptav...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 159920BDBM159920(US9682968, Example-17-25 | US10093663, Example 17-...)
Affinity DataIC50: 45nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 160473BDBM160473(US9682968, Example-25a (+) | US10093663, Example 2...)
Affinity DataIC50: 47nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251873BDBM251873(US9475806, 7-D b) (+))
Affinity DataIC50: 50nMpH: 7.4 T: 2°CAssay Description:Recombinant human factor B (expressed in drosophila cells and purified using standard methods) labeled with biotin (10 nM), europium-labeled streptav...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 182861BDBM182861(US9676728, 11-B b (-)-2-(2,2,2-Trifluoro-1-methoxy...)
Affinity DataIC50: 55nMpH: 7.4 T: 2°CAssay Description:Recombinant human factor B (expressed in drosophila cells and purified using standard methods) labeled with biotin (10 nM), europium-labeled streptav...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/16/2018
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 160506BDBM160506(US9682968, Example-40 | US10093663, Example 40)
Affinity DataIC50: 55nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251887BDBM251887(US9475806, 17-C)
Affinity DataIC50: 60nMpH: 7.4 T: 2°CAssay Description:Recombinant human factor B (expressed in drosophila cells and purified using standard methods) labeled with biotin (10 nM), europium-labeled streptav...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 159509BDBM159509(US9682968, Example-17-13 | US10093663, Example 17-...)
Affinity DataIC50: 63nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 159379BDBM159379(US9682968, Example-17-8 | US10093663, Example 17-8)
Affinity DataIC50: 70nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 289452BDBM289452(US10093663, Example 17-4)
Affinity DataIC50: 87nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251888BDBM251888(US9475806, 17-G)
Affinity DataIC50: 90nMpH: 7.4 T: 2°CAssay Description:Recombinant human factor B (expressed in drosophila cells and purified using standard methods) labeled with biotin (10 nM), europium-labeled streptav...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251870BDBM251870(US9475806, 6-C b) (-))
Affinity DataIC50: 90nMpH: 7.4 T: 2°CAssay Description:Recombinant human factor B (expressed in drosophila cells and purified using standard methods) labeled with biotin (10 nM), europium-labeled streptav...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 159841BDBM159841(US9682968, Example-17-22 | US10093663, Example 17-...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 159382BDBM159382(US9682968, Example-17-10 | US10093663, Example 17-...)
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251883BDBM251883(US9475806, 14-I b) (-))
Affinity DataIC50: 100nMpH: 7.4 T: 2°CAssay Description:Recombinant human factor B (expressed in drosophila cells and purified using standard methods) labeled with biotin (10 nM), europium-labeled streptav...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 289450BDBM289450(US10093663, Example 17-5 | US10093663, Example 17-...)
Affinity DataIC50: 120nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251872BDBM251872(US9475806, 7-D b) (-))
Affinity DataIC50: 130nMpH: 7.4 T: 2°CAssay Description:Recombinant human factor B (expressed in drosophila cells and purified using standard methods) labeled with biotin (10 nM), europium-labeled streptav...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 160501BDBM160501(US9682968, Example-38 | US10093663, Example 38)
Affinity DataIC50: 130nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 251869BDBM251869(US9475806, 5-B b) (-))
Affinity DataIC50: 140nMpH: 7.4 T: 2°CAssay Description:Recombinant human factor B (expressed in drosophila cells and purified using standard methods) labeled with biotin (10 nM), europium-labeled streptav...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 159303BDBM159303(US9682968, Example-13 | US10093663, Example 13)
Affinity DataIC50: 140nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 159932BDBM159932(US9682968, Example-17-28 | US10093663, Example 17-...)
Affinity DataIC50: 160nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 289524BDBM289524(US10093663, Example 41 | Ethyl 4-((2S,4R)-1-((5-me...)
Affinity DataIC50: 165nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 159157BDBM159157(US9682968, Example-5-4 | US10093663, Example 5-4)
Affinity DataIC50: 180nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 159302BDBM159302(US9682968, Example-12 | US10093663, Example 12)
Affinity DataIC50: 230nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

Displayed 1 to 50 (of 165 total ) | Next | Last >>
Jump to: